Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;36(5):829-847.
doi: 10.1007/s11011-021-00696-6. Epub 2021 Mar 11.

Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

Rohit Kumar Tiwari  1 , Afrasim Moin  2 , Syed Mohd Danish Rizvi  2 , Syed Monowar Alam Shahid  3 , Preeti Bajpai  4
Affiliations
Review

Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

Rohit Kumar Tiwari et al. Metab Brain Dis. 2021 Jun.

Abstract

Neurodegeneration-associated dementia disorders (NADDs), namely Alzheimer and Parkinson diseases, are developed by a significant portion of the elderly population globally. Extensive research has provided critical insights into the molecular basis of the pathological advancements of these diseases, but an efficient curative therapy seems elusive. A common attribute of NADDs is neuroinflammation due to a chronic inflammatory response within the central nervous system (CNS), which is primarily modulated by microglia. This response within the CNS is positively regulated by cytokines, chemokines, secondary messengers or cyclic nucleotides, and free radicals. Microglia mediated immune activation is regulated by a positive feedback loop in NADDs. The present review focuses on evaluating the crosstalk between inflammatory mediators and microglia, which aggravates both the clinical progression and extent of NADDs by forming a persistent chronic inflammatory milieu within the CNS. We also discuss the role of the human gut microbiota and its effect on NADDs as well as the suitability of targeting toll-like receptors for an immunotherapeutic intervention targeting the deflation of an inflamed milieu within the CNS.

Keywords: Alzheimer disease; Human microbiome; Immunotherapy; Neurodegeneration; Neuroinflammation; Parkinson disease; Toll-like receptors.

PubMed Disclaimer

References

    1. Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A, Morris C, Winblad B, Nordberg A, Zhu J (2002) Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice. J Neuroimmunol 126:50–57. https://doi.org/10.1016/S0165-5728(02)00050-4 - DOI - PubMed
    1. Abbas MM, Xu Z, Tan LC (2018) Epidemiology of Parkinson’s disease—east versus west. Mov Disord Clin Pract 5:14–28. https://doi.org/10.1002/mdc3.12568 - DOI - PubMed
    1. Alam JJ (2015) Selective brain-targeted antagonism of p38 MAPKα reduces hippocampal IL-1β levels and improves Morris water maze performance in aged rats. J Alzheimers Dis 48:219–227. https://doi.org/10.3233/JAD-150277 - DOI - PubMed - PMC
    1. Alonso AD, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91:5562–5566. https://doi.org/10.1073/pnas.91.12.5562 - DOI - PubMed - PMC
    1. Alonso AD, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783–787. https://doi.org/10.1038/nm0796-783 - DOI - PubMed

Substances

LinkOut - more resources